Total Payments
$8,552
2024 Payments
$3,161
Companies
29
Transactions
410
Medicare Patients
1,332
Medicare Billing
$247,811
Payment Breakdown by Category
Food & Beverage$8,114 (94.9%)
Education$438.01 (5.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,114 | 403 | 94.9% |
| Education | $438.01 | 7 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,204 | 67 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $792.05 | 52 | $0 (2024) |
| Janssen Biotech, Inc. | $784.67 | 38 | $0 (2024) |
| Lilly USA, LLC | $761.85 | 39 | $0 (2024) |
| GENZYME CORPORATION | $738.92 | 23 | $0 (2024) |
| PFIZER INC. | $633.30 | 42 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $446.00 | 17 | $0 (2024) |
| Amgen Inc. | $426.36 | 18 | $0 (2024) |
| Galderma Laboratories, L.P. | $310.21 | 11 | $0 (2024) |
| Incyte Corporation | $292.13 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,161 | 143 | ABBVIE INC. ($515.70) |
| 2023 | $2,113 | 102 | AbbVie Inc. ($349.91) |
| 2022 | $2,387 | 115 | GENZYME CORPORATION ($390.13) |
| 2021 | $183.80 | 4 | Galderma Laboratories, L.P. ($171.59) |
| 2020 | $222.60 | 6 | VYNE Pharmaceuticals Inc. ($125.00) |
| 2019 | $54.30 | 4 | PFIZER INC. ($29.09) |
| 2018 | $323.63 | 31 | Novartis Pharmaceuticals Corporation ($150.86) |
| 2017 | $106.96 | 5 | LEO Pharma Inc. ($45.12) |
All Payment Transactions
410 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Immunology | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.16 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Immunology | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $79.98 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $127.94 | General |
| Category: Immunology | ||||||
| 10/31/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Inflammation & Immunology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $146.58 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $39.96 | General |
| Category: Immunology | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $40.45 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 242 | 356 | $87,435 | $15,470 |
| 2022 | 10 | 263 | 322 | $46,611 | $18,658 |
| 2021 | 10 | 403 | 1,431 | $208,381 | $118,773 |
| 2020 | 12 | 424 | 1,243 | $198,587 | $94,911 |
Total Patients
1,332
Total Services
3,352
Medicare Billing
$247,811
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 35 | $15,610 | $2,804 | 18.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 47 | $14,946 | $2,794 | 18.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 23 | 26 | $10,920 | $1,864 | 17.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $8,253 | $1,487 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,566 | $1,359 | 18.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 27 | 27 | $6,966 | $1,351 | 19.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 32 | 35 | $8,575 | $1,302 | 15.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 20 | 21 | $7,980 | $1,263 | 15.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 19 | $3,819 | $717.28 | 18.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 20 | 112 | $2,800 | $528.22 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 58 | $7,782 | $3,339 | 42.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 37 | 43 | $8,275 | $3,140 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $7,560 | $3,024 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,925 | $2,776 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 25 | $4,450 | $2,464 | 55.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 22 | 23 | $4,540 | $1,568 | 34.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 25 | 26 | $3,605 | $920.85 | 25.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $1,750 | $736.31 | 42.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,257 | $406.12 | 32.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 17 | 57 | $1,467 | $283.36 | 19.3% |
| 96910 | Skin application of tar and ultraviolet b or petrolatum and ultraviolet b | Office | 2021 | 12 | 782 | $117,300 | $89,053 | 75.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 122 | $24,400 | $8,447 | 34.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 39 | 43 | $12,900 | $3,718 | 28.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 33 | 37 | $9,361 | $3,596 | 38.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 63 | 68 | $8,160 | $3,252 | 39.9% |
About Dr. Patrick Dominguez, M.D
Dr. Patrick Dominguez, M.D is a Dermatology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1184891830.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Dominguez, M.D has received a total of $8,552 in payments from pharmaceutical and medical device companies, with $3,161 received in 2024. These payments were reported across 410 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($8,114).
As a Medicare-enrolled provider, Dominguez has provided services to 1,332 Medicare beneficiaries, totaling 3,352 services with total Medicare billing of $247,811. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Orlando, FL
- Active Since 05/13/2008
- Last Updated 06/13/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1184891830
Products in Payments
- DUPIXENT (Biological) $1,212
- SKYRIZI (Biological) $873.58
- TREMFYA (Drug) $784.67
- TALTZ (Drug) $583.44
- EUCRISA (Drug) $559.18
- COSENTYX (Drug) $449.78
- Otezla (Drug) $405.70
- COSENTYX (Biological) $324.01
- Sotyktu (Drug) $282.54
- VTAMA (Drug) $272.44
- RINVOQ (Biological) $246.10
- OPZELURA (Drug) $220.13
- ADBRY (Biological) $181.71
- Bimzelx (Biological) $152.40
- AMZEEQ (Drug) $125.00
- Seysara (Drug) $115.26
- OLUMIANT (Drug) $112.02
- ILUMYA (Biological) $102.16
- SPEVIGO (Drug) $97.73
- CIBINQO (Drug) $74.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Orlando
Neil Niren, Md, MD
Dermatology — Payments: $920,001
Dermatology $920,001
Mrs. Debra Grayman, M.d, M.D
Dermatology — Payments: $152,429
Dermatology $152,429
Dr. Monique Kumar, Md, MD
Dermatology — Payments: $19,857
Dermatology $19,857
Dr. Samantha Marrone, Md, MD
Dermatology — Payments: $18,714
Dermatology $18,714
Savina Aneja
Dermatology — Payments: $17,559
Dermatology $17,559
Dr. Valenie Rivera Roig, M.d, M.D
Dermatology — Payments: $9,213
Dermatology $9,213